3-57198280-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PP3_StrongPP5
The NM_003865.3(HESX1):c.475C>T(p.Arg159Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000144 in 1,612,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003865.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HESX1 | ENST00000295934.8 | c.475C>T | p.Arg159Trp | missense_variant | Exon 4 of 4 | 1 | NM_003865.3 | ENSP00000295934.3 | ||
HESX1 | ENST00000647958.1 | c.475C>T | p.Arg159Trp | missense_variant | Exon 7 of 7 | ENSP00000498190.1 | ||||
HESX1 | ENST00000473921.2 | c.373C>T | p.Arg125Trp | missense_variant | Exon 3 of 3 | 5 | ENSP00000418918.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151970Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250890Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135760
GnomAD4 exome AF: 0.000156 AC: 228AN: 1460604Hom.: 0 Cov.: 30 AF XY: 0.000150 AC XY: 109AN XY: 726654
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151970Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74222
ClinVar
Submissions by phenotype
Septo-optic dysplasia sequence Pathogenic:2Uncertain:1
- -
- -
- -
HESX1-Related Disorders Pathogenic:1
Variant summary: HESX1 c.475C>T (p.Arg159Trp) results in a non-conservative amino acid change located in the Homeodomain (Homeodomain) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 250890 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.475C>T has been reported in the literature in at least one compound heterozygous individual affected with Combined Pituitary Hormone Deficiency and pituitary aplasia (e.g., Fang_2016). The variant has also been reported in a heterozygous individual with Septooptic dysplasia, however a second HESX1 variant was not described and segregation of the variant with disease was not demonstrated (e.g., Wojcik_2019, Pozzi_2017). At least two publications report experimental evidence evaluating an impact on protein function, demonstrating that the variant results in altered localization, reduced protein expresssion, and altered or abolished repressor activity, possibly due to altered DNA binding abilities (e.g., Fang_2016, Pozzi_2017). The following publications have been ascertained in the context of this evaluation (PMID: 27000987, 28396770, 31395954). ClinVar contains an entry for this variant (Variation ID: 1206790). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate the p.R159W variant disrupts normal protein function (PMID: 27000987, 28396770); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28396770, 31395954, 27000987) -
HESX1-related disorder Pathogenic:1
The HESX1 c.475C>T variant is predicted to result in the amino acid substitution p.Arg159Trp. The variant c.475C>T has been identified in the compound heterozygous state in a patient with pituitary aplasia (PA) and combined pituitary hormone deficiency (CPHD, Fang et al. 2016. PMID: 27000987). Additionally, this particular variant has been reported in the heterozygous state in a patient with septo-optic dysplasia (SOD) and his mother who is asymptomatic despite carrying the same variant, suggesting reduced penetrance of this variant (Pozzi et al. 2017. PMID: 28396770; Supplementary Table 3c, Wojcik et al. 2019. PubMed ID: 31395954). Functional analysis in this study showed that the p.Arg159Trp substitution may reduce the expression of HESX1 protein and impair its DNA binding properties (Pozzi et al. 2017. PMID: 28396770). This variant is reported in 0.0044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. -
Septo-optic dysplasia sequence;C2750027:GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects HESX1 function (PMID: 27000987, 28396770). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1206790). This missense change has been observed in individual(s) with clinical features of septo-optic dysplasia (PMID: 2700987, 28396770, 31395954). This variant is present in population databases (rs770886420, gnomAD 0.004%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 159 of the HESX1 protein (p.Arg159Trp). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at